keyword
MENU ▼
Read by QxMD icon Read
search

macular degeneration and p

keyword
https://www.readbyqxmd.com/read/29773175/blood-lead-and-cadmium-in-age-related-macular-degeneration-in-a-turkish-urban-population
#1
Elif Damar Güngör, Fatma Yülek, Utku Serkant, Yasin Toklu, Asım Hocaoğlu, Şaban Şimsek
PURPOSE: To evaluate the blood lead (Pb) and cadmium (Cd) levels in age related macular degeneration (AMD) in a turkish urban population. METHODS: Blood Pb and Cd levels of 31 AMD patients and 24 age and gender matched controls with no sign of AMD were measured using dual atomic absorption spectrophotometer system (AAS). History of hypertension, diabetes mellitus, cigarette smoking, myocardial infarction and stroke were obtained from all subjects. Degree of AMD was grade 4 according to the Age-Related Eye Disease Study grading system...
July 2018: Journal of Trace Elements in Medicine and Biology
https://www.readbyqxmd.com/read/29772042/subfoveal-choroidal-thickness-as-a-potential-predictor-of-clinical-response-to-stereotactic-radiotherapy-for-neovascular-age-related-macular-degeneration
#2
Mahdy Ranjbar, Maximilian Kurz, Annekatrin Holzhey, Dirk Rades, Salvatore Grisanti
BACKGROUND AND OBJECTIVE: Stereotactic radiotherapy (SRT) is a new adjuvant treatment modality that has been shown to reduce the need for repetitive intravitreal injections (IVIs) in patients with neovascular age-related macular degeneration (nAMD). The authors aimed to determine baseline predictors of clinical response to SRT. PATIENTS AND METHODS: This was a retrospective, observational case series of patients with nAMD who underwent SRT and subsequently had at least 12 months of complete follow-up...
May 1, 2018: Ophthalmic Surgery, Lasers & Imaging Retina
https://www.readbyqxmd.com/read/29772018/the-cost-effectiveness-of-bevacizumab-ranibizumab-and-aflibercept-for-the-treatment-of-age-related-macular-degeneration-a-cost-effectiveness-analysis-from-a-societal-perspective
#3
Freekje van Asten, Charlotte T J Michels, Carel B Hoyng, Gert Jan van der Wilt, B Jeroen Klevering, Maroeska M Rovers, Janneke P C Grutters
BACKGROUND: The discussion on the use of bevacizumab is still ongoing and often doctors are deterred from using bevacizumab due to legal or political issues. Bevacizumab is an effective, safe and inexpensive treatment option for neovascular age-related macular degeneration (AMD), albeit unregistered for the disease. Therefore, in some countries ophthalmologists use the equally effective but expensive drugs ranibizumab and aflibercept. We describe the economic consequences of this dilemma surrounding AMD treatment from a societal perspective...
2018: PloS One
https://www.readbyqxmd.com/read/29769799/placental-growth-factor-promotes-epithelial-mesenchymal-transition-like-changes-in-arpe-19-cells-under-hypoxia
#4
Yi Zhang, Lin Zhao, Lijun Wang, Xiting Yang, Aiyi Zhou, Jianming Wang
Purpose: To investigate the role of placental growth factor (PGF) in the epithelial-mesenchymal transition (EMT) of ARPE-19 cells under hypoxia, and whether the NF-κB signaling pathway is involved in this process. Methods: ARPE-19 cells were treated in five groups: a control group, hypoxia group, PGF group, hypoxia+PGF group, and NF-κB-blocked group. A chemical hypoxia model was established in the ARPE-19 cells by adding CoCl2 to the culture medium. The morphological changes after treatment were observed...
2018: Molecular Vision
https://www.readbyqxmd.com/read/29768266/subfoveal-choroidal-thickness-in-eyes-with-neovascular-age-related-macular-degeneration-treated-with-anti-vascular-endothelial-growth-factor-agents
#5
Tereza Cristina Moreira Kanadani, Carlos Eduardo Veloso, Márcio B Nehemy
PURPOSE: We aimed to assess the subfoveal choroidal thickness (SFChT) and the effect of treatment with anti-vascular endothelial growth factor (anti-VEGF) agents on the SFChT in age-related macular degeneration (AMD) subtypes. METHODS: We enrolled 128 eyes of 107 patients with neovascular AMD (60 women; 47 men; mean age, 73.6 ± 8.9 years), and prospectively evaluated the best-corrected visual acuity (BCVA) and SFChT at baseline and at 3, 6, and 12 months after treatment with anti-VEGF agents...
May 16, 2018: Ophthalmologica. Journal International D'ophtalmologie
https://www.readbyqxmd.com/read/29767815/the-effect-of-glatiramer-acetate-on-retinal-nerve-fiber-layer-thickness-in-patients-with-relapsing-remitting-multiple-sclerosis-a-longitudinal-optical-coherence-tomography-study
#6
Robert Zivadinov, Eleonora Tavazzi, Jesper Hagemeier, Ellen Carl, David Hojnacki, Channa Kolb, Bianca Weinstock-Guttman
BACKGROUND: Optical coherence tomography (OCT) is a technique that allows for the assessment of retinal nerve fiber layer thickness (RNFLT) and total macular volume (TMV), which reflect neuroaxonal integrity within the retina. As such it has been used in multiple sclerosis (MS) to study neurodegeneration. Glatiramer acetate (GA) is a widely used treatment for MS, which is suggested to have a possible neuroprotective role. OBJECTIVE: The aim of this study was to assess RFNLT and TMV changes in relapsing-remitting MS (RRMS) patients who started treatment with GA and were followed for a 24-month period...
May 16, 2018: CNS Drugs
https://www.readbyqxmd.com/read/29767720/functional-analyses-of-rare-genetic-variants-in-complement-component-c9-identified-in-patients-with-age-related-macular-degeneration
#7
Mariann Kremlitzka, Maartje J Geerlings, Sarah de Jong, Bjorn Bakker, Sara C Nilsson, Sascha Fauser, Carel B Hoyng, Eiko K de Jong, Anneke I den Hollander, Anna M Blom
Age-related macular degeneration (AMD) is a progressive disease of the central retina and the leading cause of irreversible vision loss in the western world. The involvement of abnormal complement activation in AMD has been suggested by association of variants in genes encoding complement proteins with disease development. A low-frequency variant (p.P167S) in the complement component C9 (C9) gene was recently shown to be highly associated with AMD, however its functional outcome remains largely unexplored. In this study, we reveal five novel rare genetic variants (p...
May 14, 2018: Human Molecular Genetics
https://www.readbyqxmd.com/read/29760528/lrrtm4-c538y-novel-gene-mutation-is-associated-with-hereditary-macular-degeneration-with-novel-dysfunction-of-on-type-bipolar-cells
#8
Yuichi Kawamura, Akiko Suga, Takuro Fujimaki, Kazutoshi Yoshitake, Kazushige Tsunoda, Akira Murakami, Takeshi Iwata
The macula is a unique structure in higher primates, where cone and rod photoreceptors show highest density in the fovea and the surrounding area, respectively. The hereditary macular dystrophies represent a heterozygous group of rare disorders characterized by central visual loss and atrophy of the macula and surrounding retina. Here we report an atypical absence of ON-type bipolar cell response in a Japanese patient with autosomal dominant macular dystrophy (adMD). To identify a causal genetic mutation for the adMD, we performed whole-exome sequencing (WES) on four affected and four-non affected members of the family for three generations, and identified a novel p...
May 14, 2018: Journal of Human Genetics
https://www.readbyqxmd.com/read/29753724/id2-protects-retinal-pigment-epithelium-cells-from-oxidative-damage-through-p-erk1-2-id2-nrf2
#9
Yuting Fan, Zixin Huang, Chongde Long, Jie Ning, Han Zhang, Xielan Kuang, Qingjiong Zhang, Huangxuan Shen
Age-related macular degeneration (AMD) is the leading cause of blindness during aging. The degeneration of retinal pigment epithelium (RPE) is the main pathologic characteristic of AMD. ID2 is a member of the Inhibitor of DNA binding proteins (ID) family and is involved in regulation of cell proliferation and differentiation. However, currently the role of ID2 in oxidative injury response in RPE cells remains unknown. Here we showed that oxidative stress increased ID2 expression in RPE cells. Knockdown of ID2 promoted cell apoptosis and increased ROS level in RPE cells that were subjected to oxidative damage...
May 10, 2018: Archives of Biochemistry and Biophysics
https://www.readbyqxmd.com/read/29753123/photodynamic-therapy-in-combination-with-ranibizumab-versus-ranibizumab-monotherapy-for-wet-age-related-macular-degeneration-a-systematic-review-and-meta-analysis
#10
REVIEW
Yongxian Su, Jiawei Wu, Yu Gu
OBJECTIVE: To evaluate the efficacy and safety between photodynamic therapy (PDT) combined with intravitreal ranibizumab (IVR) and ranibizumab monotherapy in treating wet age-related macular degeneration (AMD). METHODS: A systematic search was performed in the PubMed, Embase, Web of Science and the Cochrane Library databases through December 31, 2017. The methodological quality of the references was evaluated according to the Cochrane quality assessment. RevMan 5...
May 9, 2018: Photodiagnosis and Photodynamic Therapy
https://www.readbyqxmd.com/read/29752877/characterization-of-rpe-melanin-and-degraded-synthetic-melanin-using-mass-spectrometry-and-in-vitro-biochemical-diagnostics
#11
Sally M Yacout, Kelsey L McIlwain, Shama P Mirza, Elizabeth R Gaillard
With increasing age, there is an observable loss of melanin in retinal pigment epithelial (RPE) cells. It is possible that degradation of the pigment contributes to the pathogenesis of retinal disease, as the cellular antioxidant material is depleted. Functionally, intact melanin maintains protective qualities, while oxidative degradation of melanin promotes reactive oxygen species (ROS) generation and formation of metabolic byproducts, such as melanolipofuscin. Understanding the structural and functional changes to RPE melanin with increasing age may contribute to a better understanding of disease progression and risk factors for conditions such as Age-related macular degeneration (AMD)...
May 12, 2018: Photochemistry and Photobiology
https://www.readbyqxmd.com/read/29746512/visual-acuity-and-contrast-sensitivity-are-two-important-factors-affecting-vision-related-quality-of-life-in-advanced-age-related-macular-degeneration
#12
Miin Roh, Alexandra Selivanova, Hyun Joon Shin, Joan W Miller, Mary Lou Jackson
PURPOSE: Vision loss from age-related macular degeneration (AMD) has a profound effect on vision-related quality of life (VRQoL). The pupose of this study is to identify clinical factors associated with VRQoL using the Rasch- calibrated NEI VFQ-25 scales in bilateral advanced AMD patients. METHODS: We retrospectively reviewed 47 patients (mean age 83.2 years) with bilateral advanced AMD. Clinical assessment included age, gender, type of AMD, high contrast visual acuity (VA), history of medical conditions, contrast sensitivity (CS), central visual field loss, report of Charles Bonnet Syndrome, current treatment for AMD and Rasch-calibrated NEI VFQ-25 visual function and socioemotional function scales...
2018: PloS One
https://www.readbyqxmd.com/read/29746411/reduced-choriocapillaris-flow-in-eyes-with-type-3-neovascularization-and-age-related-macular-degeneration
#13
Enrico Borrelli, Eric H Souied, K Bailey Freund, Giuseppe Querques, Alexandra Miere, Orly Gal-Or, Riccardo Sacconi, SriniVas R Sadda, David Sarraf
PURPOSE: To study choriocapillaris (CC) flow in eyes with Type 3 neovascularization (NV) and age-related macular degeneration, using optical coherence tomography angiography analysis. METHODS: In this multicenter, retrospective, observational study, we collected data from 21 patients with unilateral Type 3 NV and age-related macular degeneration, based on clinical examination, structural optical coherence tomography, and fluorescein angiography when available. An additional group of 20 nonneovascular age-related macular degeneration eyes with unilateral Type 1 or Type 2 NV due to age-related macular degeneration was included for comparison...
April 30, 2018: Retina
https://www.readbyqxmd.com/read/29746403/amish-eye-study-baseline-spectral-domain-optical-coherence-tomography-characteristics-of-age-related-macular-degeneration
#14
Muneeswar G Nittala, Yeunjoo E Song, Rebecca Sardell, Larry D Adams, Samuel Pan, Swetha B Velaga, Violet Horst, Debra Dana, Laura Caywood, Renee Laux, Denise Fuzzell, Sarada Fuzzell, William K Scott, Jessica N Cooke Bailey, Robert P Igo, Jonathan Haines, Margaret A Pericak-Vance, SriniVas R Sadda, Dwight Stambolian
PURPOSE: To describe spectral domain optical coherence tomography (SD-OCT) findings in an Amish cohort to assess SD-OCT markers for early age-related macular degeneration (AMD). METHODS: The authors performed a family-based prospective cohort study of 1,146 elderly Amish subjects (age range 50-99 years) (2,292 eyes) who had a family history of at least 1 individual with AMD. All subjects underwent complete ophthalmic examinations, SD-OCT using both Cirrus and Spectralis (20 × 20° scan area) instruments, fundus autofluorescence, infrared imaging, and color fundus photography...
May 9, 2018: Retina
https://www.readbyqxmd.com/read/29743491/classical-and-alternative-complement-activation-on-photoreceptor-outer-segments-drives-monocyte-dependent-retinal-atrophy
#15
Kenneth J Katschke, Hongkang Xi, Christian Cox, Tom Truong, Yann Malato, Wyne P Lee, Brent McKenzie, Rommel Arceo, Jianhua Tao, Linda Rangell, Mike Reichelt, Lauri Diehl, Justin Elstrott, Robby M Weimer, Menno van Lookeren Campagne
Geographic atrophy (GA), the advanced form of dry age-related macular degeneration (AMD), is characterized by progressive loss of retinal pigment epithelium cells and photoreceptors in the setting of characteristic extracellular deposits and remains a serious unmet medical need. While genetic predisposition to AMD is dominated by polymorphisms in complement genes, it remains unclear how complement activation contributes to retinal atrophy. Here we demonstrate that complement is activated on photoreceptor outer segments (POS) in the retina peripheral to atrophic lesions associated with GA...
May 9, 2018: Scientific Reports
https://www.readbyqxmd.com/read/29739007/optical-coherence-tomography-angiography-to-quantify-choroidal-neovascularization-in-response-to-aflibercept
#16
Jun Takeuchi, Keiko Kataoka, Yasuki Ito, Kei Takayama, Tetsuhiro Yasuma, Hiroki Kaneko, Hiroko Terasaki
PURPOSE: To investigate the microvascular changes in choroidal<X00_Del_Blind>0</X00_Del_Blind> neovascularization (CNV) using optical coherence tomography angiography (OCTA) during anti-vascular endothelial growth factor (VEGF) therapies. METHODS: We retrospectively collected data on consecutive treatment-naïve eyes with typical age-related macular degeneration that initially received 3 aflibercept injections. OCTA was performed at baseline and at 1, 2, and 4 months of follow-up...
May 8, 2018: Ophthalmologica. Journal International D'ophtalmologie
https://www.readbyqxmd.com/read/29734180/influence-of-the-vitreoretinal-interface-on-the-treatment-with-anti-vegf-for-exudative-age-related-macular-degeneration
#17
Pedro Gil, João Gil, Nuno Oliveira, Inês Laíns, Eduardo Nery Rossi Camilo, Cristina Fonseca, Miguel Raimundo, Maria da Luz Cachulo, Rufino Silva
PURPOSE: To investigate the influence of the vitreoretinal interface on the outcomes of different ranibizumab regimens for exudative age-related macular degeneration. METHODS: We conducted a retrospective subanalysis of 2 prospective clinical trials. Patients were treated with ranibizumab for 12 months according to 3 different regimens: pro-re-nata (PRN), treat and extend (T&amp;E), and monthly. Vitreoretinal interface was assessed for absence (group ON) or presence (group OFF) of posterior vitreous detachment (PVD)...
May 7, 2018: Ophthalmologica. Journal International D'ophtalmologie
https://www.readbyqxmd.com/read/29721037/automated-segmentation-methods-of-drusen-to-diagnose-age-related-macular-degeneration-screening-in-retinal-images
#18
Young Jae Kim, Kwang Gi Kim
Existing drusen measurement is difficult to use in clinic because it requires a lot of time and effort for visual inspection. In order to resolve this problem, we propose an automatic drusen detection method to help clinical diagnosis of age-related macular degeneration. First, we changed the fundus image to a green channel and extracted the ROI of the macular area based on the optic disk. Next, we detected the candidate group using the difference image of the median filter within the ROI. We also segmented vessels and removed them from the image...
2018: Computational and Mathematical Methods in Medicine
https://www.readbyqxmd.com/read/29716784/emixustat-hydrochloride-for-geographic-atrophy-secondary-to-age-related-macular-degeneration-a-randomized-clinical-trial
#19
Philip J Rosenfeld, Pravin U Dugel, Frank G Holz, Jeffrey S Heier, Joel A Pearlman, Roger L Novack, Karl G Csaky, John M Koester, Jeffrey K Gregory, Ryo Kubota
PURPOSE: To determine whether emixustat hydrochloride (emixustat) reduces the rate of enlargement of geographic atrophy (GA) compared with placebo in subjects with age-related macular degeneration (AMD) and to evaluate the safety and tolerability of emixustat over 24 months of treatment. DESIGN: Multicenter, randomized, double-masked, placebo-controlled, phase 2b/3 clinical trial. PARTICIPANTS: Patients with GA secondary to AMD, a visual acuity score of at least 35 letters, and GA with a total area of 1...
April 28, 2018: Ophthalmology
https://www.readbyqxmd.com/read/29713139/foveal-threshold-and-photoreceptor-integrity-for-prediction-of-visual-acuity-after-intravitreal-aflibercept-on-age-related-macular-degeneration
#20
Tsutomu Sakai, Sachiyo Okude, Hiroshi Tsuneoka
Purpose: To determine whether baseline foveal threshold and photoreceptor integrity can predict best-corrected visual acuity (BCVA) at 12 months after intravitreal aflibercept (IVA) therapy in eyes with neovascular age-related macular degeneration (AMD). Patients and methods: We evaluated 25 eyes of 25 patients with treatment-naïve neovascular AMD who received IVA once a month for 3 months, followed by once every 2 months for 8 months. BCVA, integrity of the external limiting membrane (ELM) or the ellipsoid zone (EZ) of the photoreceptors, and retinal sensitivity were determined before (baseline) and at 6 and 12 months after initial IVA...
2018: Clinical Ophthalmology
keyword
keyword
102809
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"